Elevance Health Share Holder Equity 2010-2024 | ELV
Elevance Health share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
- Elevance Health share holder equity for the quarter ending March 31, 2024 was $40.710B, a 8.68% increase year-over-year.
- Elevance Health share holder equity for 2023 was $39.405B, a 8.46% increase from 2022.
- Elevance Health share holder equity for 2022 was $36.33B, a 0.56% increase from 2021.
- Elevance Health share holder equity for 2021 was $36.128B, a 8.82% increase from 2020.
| Elevance Health Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023 | $39,405 |
| 2022 | $36,330 |
| 2021 | $36,128 |
| 2020 | $33,199 |
| 2019 | $31,728 |
| 2018 | $28,541 |
| 2017 | $26,503 |
| 2016 | $25,100 |
| 2015 | $23,044 |
| 2014 | $24,251 |
| 2013 | $24,765 |
| 2012 | $23,803 |
| 2011 | $23,288 |
| 2010 | $23,813 |
| 2009 | $24,863 |
| Elevance Health Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024-03-31 | $40,710 |
| 2023-12-31 | $39,405 |
| 2023-09-30 | $38,539 |
| 2023-06-30 | $38,312 |
| 2023-03-31 | $37,460 |
| 2022-12-31 | $36,330 |
| 2022-09-30 | $36,043 |
| 2022-06-30 | $35,867 |
| 2022-03-31 | $36,031 |
| 2021-12-31 | $36,128 |
| 2021-09-30 | $35,808 |
| 2021-06-30 | $35,046 |
| 2021-03-31 | $33,918 |
| 2020-12-31 | $33,199 |
| 2020-09-30 | $33,921 |
| 2020-06-30 | $34,455 |
| 2020-03-31 | $31,693 |
| 2019-12-31 | $31,728 |
| 2019-09-30 | $31,332 |
| 2019-06-30 | $30,793 |
| 2019-03-31 | $29,998 |
| 2018-12-31 | $28,541 |
| 2018-09-30 | $29,094 |
| 2018-06-30 | $28,725 |
| 2018-03-31 | $27,012 |
| 2017-12-31 | $26,503 |
| 2017-09-30 | $25,948 |
| 2017-06-30 | $26,432 |
| 2017-03-31 | $26,092 |
| 2016-12-31 | $25,100 |
| 2016-09-30 | $24,744 |
| 2016-06-30 | $24,234 |
| 2016-03-31 | $23,547 |
| 2015-12-31 | $23,044 |
| 2015-09-30 | $23,236 |
| 2015-06-30 | $23,063 |
| 2015-03-31 | $24,334 |
| 2014-12-31 | $24,251 |
| 2014-09-30 | $24,294 |
| 2014-06-30 | $24,377 |
| 2014-03-31 | $24,345 |
| 2013-12-31 | $24,765 |
| 2013-09-30 | $24,808 |
| 2013-06-30 | $24,533 |
| 2013-03-31 | $24,318 |
| 2012-12-31 | $23,803 |
| 2012-09-30 | $23,817 |
| 2012-06-30 | $23,644 |
| 2012-03-31 | $23,528 |
| 2011-12-31 | $23,288 |
| 2011-09-30 | $23,718 |
| 2011-06-30 | $24,181 |
| 2011-03-31 | $23,978 |
| 2010-12-31 | $23,813 |
| 2010-09-30 | $24,362 |
| 2010-06-30 | $23,791 |
| 2010-03-31 | $24,519 |
| 2009-12-31 | $24,863 |
| 2009-09-30 | $22,867 |
| 2009-06-30 | $22,253 |
| 2009-03-31 | $21,508 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $125.903B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $47.741B | 18.61 |
| ICON (ICLR) | Ireland | $26.139B | 24.68 |
| DiDi Global (DIDIY) | China | $21.386B | 0.00 |
| Avantor (AVTR) | United States | $15.283B | 22.50 |
| CochLear (CHEOY) | Australia | $14.173B | 0.00 |
| Revvity (RVTY) | United States | $13.191B | 23.14 |
| Natera (NTRA) | United States | $13.190B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.644B | 41.60 |
| Viatris (VTRS) | United States | $12.466B | 3.73 |
| Charles River Laboratories (CRL) | United States | $10.809B | 20.69 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.137B | 0.00 |
| Solventum (SOLV) | United States | $8.860B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.681B | 0.00 |
| HealthEquity (HQY) | United States | $7.198B | 46.21 |
| Organon (OGN) | United States | $5.431B | 5.15 |
| Bausch + Lomb (BLCO) | Canada | $5.256B | 21.04 |
| Doximity (DOCS) | United States | $5.107B | 35.77 |
| PACS (PACS) | United States | $4.437B | 0.00 |
| Life Times (LTH) | United States | $3.623B | 37.96 |
| Sotera Health (SHC) | United States | $3.369B | 16.53 |
| Surgery Partners (SGRY) | United States | $3.017B | 27.60 |
| GoodRx Holdings (GDRX) | United States | $2.859B | 108.86 |
| Agilon Health (AGL) | United States | $2.677B | 0.00 |
| Progyny (PGNY) | United States | $2.487B | 42.82 |
| AMN Healthcare Services Inc (AMN) | United States | $2.029B | 8.04 |
| NovoCure (NVCR) | Jersey | $2.014B | 0.00 |
| Premier (PINC) | United States | $1.949B | 8.34 |
| BrightSpring Health Services (BTSG) | United States | $1.852B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.757B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.449B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.226B | 0.00 | |
| CareDx (CDNA) | United States | $0.749B | 0.00 |
| Embecta (EMBC) | United States | $0.722B | 4.91 |
| GeneDx Holdings (WGS) | United States | $0.717B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.695B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.680B | 7.21 |
| Auna S.A (AUNA) | Luxembourg | $0.568B | 0.00 |
| Sharecare (SHCR) | United States | $0.497B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.430B | 0.00 |
| Enhabit (EHAB) | United States | $0.426B | 42.50 |
| ModivCare (MODV) | United States | $0.367B | 6.87 |
| Sonida Senior Living (SNDA) | United States | $0.345B | 0.00 |
| DocGo (DCGO) | United States | $0.310B | 16.94 |
| LifeMD (LFMD) | United States | $0.288B | 0.00 |
| MultiPlan (MPLN) | United States | $0.238B | 0.00 |
| Beauty Health (SKIN) | United States | $0.223B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.212B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.204B | 0.00 |
| Biodesix (BDSX) | United States | $0.189B | 0.00 |
| So-Young (SY) | China | $0.111B | 53.49 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 5.88 |
| Co-Diagnostics (CODX) | United States | $0.043B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.035B | 0.00 |
| Oncology Institute (TOI) | United States | $0.031B | 0.00 |
| Nutex Health (NUTX) | United States | $0.029B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.025B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.023B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| KindlyMD (KDLY) | $0.018B | 0.00 | |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.002B | 0.00 |